GW Henssler & Associates Ltd. increased its position in Cerner Corp. (NASDAQ:CERN) by 9.8% during the second quarter, Holdings Channel reports. The institutional investor owned 167,903 shares of the company’s stock after buying an additional 14,921 shares during the period. GW Henssler & Associates Ltd.’s holdings in Cerner Corp. were worth $9,839,000 as of its most recent filing with the SEC.
Other hedge funds also recently modified their holdings of the company. Acrospire Investment Management LLC bought a new stake in shares of Cerner Corp. during the first quarter worth about $106,000. Alpha Windward LLC increased its stake in shares of Cerner Corp. by 2.2% in the second quarter. Alpha Windward LLC now owns 2,061 shares of the company’s stock worth $121,000 after buying an additional 44 shares in the last quarter. NN Investment Partners Holdings N.V. increased its stake in shares of Cerner Corp. by 16.8% in the second quarter. NN Investment Partners Holdings N.V. now owns 2,085 shares of the company’s stock worth $122,000 after buying an additional 300 shares in the last quarter. CWM LLC increased its stake in shares of Cerner Corp. by 1,785.7% in the second quarter. CWM LLC now owns 2,112 shares of the company’s stock worth $124,000 after buying an additional 2,000 shares in the last quarter. Finally, Checchi Capital Advisers LLC increased its stake in shares of Cerner Corp. by 2.7% in the second quarter. Checchi Capital Advisers LLC now owns 2,700 shares of the company’s stock worth $158,000 after buying an additional 72 shares in the last quarter. Institutional investors own 81.39% of the company’s stock.
Shares of Cerner Corp. (NASDAQ:CERN) traded down 0.51% during midday trading on Friday, reaching $60.95. The company’s stock had a trading volume of 1,176,644 shares. Cerner Corp. has a 12-month low of $49.59 and a 12-month high of $68.31. The company has a market cap of $20.58 billion, a P/E ratio of 33.47 and a beta of 0.79. The stock’s 50-day moving average price is $62.66 and its 200-day moving average price is $59.32.
Cerner Corp. (NASDAQ:CERN) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.58 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.01. Cerner Corp. had a return on equity of 18.57% and a net margin of 13.53%. The company had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.21 billion. During the same quarter in the prior year, the business earned $0.52 EPS. Cerner Corp.’s revenue was up 8.0% on a year-over-year basis. On average, analysts expect that Cerner Corp. will post $2.36 EPS for the current fiscal year.
A number of brokerages recently issued reports on CERN. Canaccord Genuity restated a “buy” rating and issued a $68.00 price target on shares of Cerner Corp. in a research report on Sunday, September 11th. Wells Fargo & Co. restated a “buy” rating on shares of Cerner Corp. in a research report on Sunday, June 26th. Piper Jaffray Cos. restated an “overweight” rating and issued a $81.00 price target on shares of Cerner Corp. in a research report on Monday, August 29th. Deutsche Bank AG lowered their price target on Cerner Corp. from $67.00 to $66.00 and set a “buy” rating for the company in a research report on Wednesday, August 3rd. Finally, Stifel Nicolaus began coverage on Cerner Corp. in a research report on Wednesday, August 31st. They issued a “hold” rating for the company. Nine investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $66.35.
In other Cerner Corp. news, Chairman Neal L. Patterson sold 428,638 shares of the company’s stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $67.14, for a total transaction of $28,778,755.32. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Vice Chairman Clifford W. Illig sold 325,705 shares of the company’s stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $65.10, for a total value of $21,203,395.50. Following the sale, the insider now owns 6,652,392 shares in the company, valued at approximately $433,070,719.20. The disclosure for this sale can be found here. Company insiders own 13.20% of the company’s stock.
Cerner Corp. Company Profile
Cerner Corporation is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. Its segments include Domestic and Global. The Domestic segment includes the business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Corp. (NASDAQ:CERN).
Receive News & Ratings for Cerner Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corp. and related companies with MarketBeat.com's FREE daily email newsletter.